Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse
- PMID: 21850156
- PMCID: PMC3137556
Increased tumor necrosis factor-α, cleaved caspase 3 levels and insulin receptor substrate-1 phosphorylation in the β₁-adrenergic receptor knockout mouse
Abstract
Purpose: To investigate the role of β1-adrenergic receptors on insulin like growth factor (IGF)-1 receptor signaling and apoptosis in the retina using β1-adrenergic receptor knockout (KO) mice.
Methods: Western blotting and enzyme-linked immunosorbent assay analyses were done on whole retinal lysates from β1-adrenergic receptor KO mice and wild-type littermates. In addition, vascular analyses of degenerate capillaries and pericyte ghosts were done on the retina of the β1-adrenergic receptor KO mice versus littermates.
Results: Lack of β1-adrenergic receptors produced a significant increase in both degenerate capillaries and pericyte ghosts. This was accompanied by an increase in cleaved caspase 3 and tumor necrosis factor α levels. IGF-1 receptor phosphorylation was not changed; however, protein kinase B (Akt) phosphorylation was significantly decreased. The decrease in Akt phosphorylation is likely caused by increased insulin receptor substrate-1 serine 307 (IRS-1(Ser307)) phosphorylation, which is inhibitory to IGF-1 receptor signaling.
Conclusions: These studies further support the idea that maintenance of β-adrenergic receptor signaling is beneficial for retinal homeostasis. Loss of β1-adrenergic receptor signaling alters tumor necrosis factor α and apoptosis levels in the retina, as well as Akt and IGF-1 receptor phosphorylation. Since many of these same changes are observed in the diabetic retina, these data support that novel β-adrenergic receptor agents may provide additional avenues for therapeutics.
Figures







Similar articles
-
Role of β-adrenergic receptor regulation of TNF-α and insulin signaling in retinal Muller cells.Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9527-33. doi: 10.1167/iovs.11-8631. Invest Ophthalmol Vis Sci. 2011. PMID: 22110065 Free PMC article.
-
Effects of insulin-like growth factor-1 (IGF-1) receptor signaling on rates of apoptosis in retina of dopamine beta hydroxylase (Dbh-/-) knockout mice.Auton Neurosci. 2010 Jan 15;152(1-2):21-6. doi: 10.1016/j.autneu.2009.08.014. Epub 2009 Sep 12. Auton Neurosci. 2010. PMID: 19748322 Free PMC article.
-
β1-adrenergic receptor stimulation by agonist Compound 49b restores insulin receptor signal transduction in vivo.Mol Vis. 2014 Jun 21;20:872-80. eCollection 2014. Mol Vis. 2014. PMID: 24966659 Free PMC article.
-
Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.Diabetes Obes Metab. 2008 Jan;10(1):53-63. doi: 10.1111/j.1463-1326.2007.00795.x. Epub 2007 Oct 15. Diabetes Obes Metab. 2008. PMID: 17941874 Review.
-
IRS proteins and diabetic complications.Diabetologia. 2016 Nov;59(11):2280-2291. doi: 10.1007/s00125-016-4072-7. Epub 2016 Aug 11. Diabetologia. 2016. PMID: 27514532 Free PMC article. Review.
Cited by
-
Role of β-adrenergic receptor regulation of TNF-α and insulin signaling in retinal Muller cells.Invest Ophthalmol Vis Sci. 2011 Dec 16;52(13):9527-33. doi: 10.1167/iovs.11-8631. Invest Ophthalmol Vis Sci. 2011. PMID: 22110065 Free PMC article.
-
TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cells.PLoS One. 2014 Jul 29;9(7):e103578. doi: 10.1371/journal.pone.0103578. eCollection 2014. PLoS One. 2014. PMID: 25073020 Free PMC article.
-
IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis.Invest Ophthalmol Vis Sci. 2013 Aug 9;54(8):5376-84. doi: 10.1167/iovs.13-12497. Invest Ophthalmol Vis Sci. 2013. PMID: 23868984 Free PMC article.
-
Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions.Mol Vis. 2013 Apr 5;19:796-803. Print 2013. Mol Vis. 2013. PMID: 23592916 Free PMC article.
-
Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism.JAMA Ophthalmol. 2013 Mar;131(3):376-82. doi: 10.1001/jamaophthalmol.2013.1476. JAMA Ophthalmol. 2013. PMID: 23303344 Free PMC article.
References
-
- Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest. 1996;75:325–38. - PubMed
-
- Wautier JL, Schmidt AM. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res. 2004;95:233–8. - PubMed
-
- Joussen AM, Poulaki V, Mitsiades N, Cai WY, Suzuma I, Pak J, Ju ST, Rook SL, Esser P, Mitsiades CS, Kirchhof B, Adamis AP, Aiello LP. Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. FASEB J. 2003;17:76–8. - PubMed
-
- Wiley LA, Rupp GR, Steinle JJ. Sympathetic innervation regulates basement membrane thickening and pericyte number in rat retina. Invest Ophthalmol Vis Sci. 2005;46:744–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous